News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Conference News NY Valves 2025 Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication Todd Neale June 27, 2025
News Conference News EuroPCR 2025 Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage Yael L. Maxwell May 21, 2025
News Conference News SCAI 2025 Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR L.A. McKeown May 02, 2025
News Daily News FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis Michael O'Riordan May 01, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Daily News Surgery Beneficial Even in Early-Stage Aortic Stenosis, RECOVERY Hints L.A. McKeown January 25, 2021
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Daily News Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease L.A. McKeown November 01, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019